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A B S T R A C T
Purpose
There are 1.2 million long-term cancer survivors in the United Kingdom. Existing research on the health and
supportive care needs of these survivors is sparse and inconclusive. This study investigated health status,
psychological morbidity, and supportive care needs in long-term cancer survivors in the United Kingdom.
Methods
Five to 16 years after diagnosis, 1,275 eligible survivors of breast, colorectal, and prostate cancers
were approached to participate in a questionnaire survey. The questionnaire explored health status
(European Quality of Life–5 Dimensions), psychological morbidity (Hospital Anxiety and Depres-
sion Scale), and supportive care needs (Cancer Survivors’ Unmet Needs Measure). Data were
analyzed by type of cancer and time since diagnosis. Logistic regression was used to identify
predictors of unmet supportive care needs.
Results
The response rate was 51.7% (659 survivors). Overall health status and levels of psychological
morbidity were consistent with population norms. At least one unmet supportive care need was
reported by 47.4% of survivors, but overall numbers of unmet needs were low (mean, 2.8;
standard deviation, 4.8). The most frequently endorsed unmet need was for help to manage
concerns about cancer recurrence. Trait anxiety (P  .001), nondischarged status (P  .01),
dissatisfaction with discharge (P  .01), and receipt of hormonal therapy (P  .01) were predictive
of unmet supportive care needs.
Conclusion
The findings suggest a majority of long-term breast, colorectal, and prostate cancer survivors who
have no signs of recurrence report good health and do not have psychological morbidity or large
numbers of unmet supportive care needs. A minority of long-term survivors may benefit from
ongoing support. The identification and support of those long-term survivors with ongoing needs
is a key challenge for health care professionals.
J Clin Oncol 29:2091-2098. © 2011 by American Society of Clinical Oncology
INTRODUCTION
There are currently 2million cancer survivors in the
United Kingdom. Of these, 1.2 million were diag-
nosed 5 or more years ago.1 The number of long-
term cancer survivors is likely to continue to grow
because of the rising incidence of cancer and im-
proving survival rates.2 Understanding the health
and supportive care needs of this population is
therefore becoming increasingly important.
The impact of cancer does not end once treat-
ment and routine hospital follow-up are complete.
Long-termcancer survivors (5ormoreyearspostdiag-
nosis) may continue to live with uncertainty over po-
tential physical3-7 and mental health problems,8-10
quality-of-life issues,11-13 and information and sup-
port needs.14
Existing research on the psychosocial implica-
tions for long-term cancer survivors is sparse and in-
conclusive.15Somestudieshavefoundongoingmental
healthproblemsandquality-of-life issues in long-term
survivors of different cancers,8-13,16,17 whereas
other studies suggest that mental health and qual-
ity of life in this population are not significantly
compromised.18-20 In its recent recommendations, the
National Cancer Survivorship Initiative in the United
Kingdomprioritizes the need to understand the natu-
ral history of survivorship and create risk-stratification
tools to determine the appropriate aftercare for cancer
survivors.21 The challenge then is to identify those
survivors who do have ongoing health and sup-
portive care needs when they are discharged from
routine hospital follow-up so that additional care
and support can be provided to those who need it.
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In contrast with the United States, most cancer survivors in the
United Kingdom are cared for exclusively by primary care physicians
(PCPs) by 5 years postdiagnosis. Therefore, the role of primary care is
particularly important in the long-term care of cancer survivors in the
United Kingdom.3,22 PCPs are well positioned to identify those survi-
vors requiring additional support andmanage the ongoinghealth and
supportive care needs of cancer survivors.22a,23 Following the US
model, the introduction of survivorship care plans (SCPs) in the
United Kingdomwill help to ensure PCPs are informed of survivors’
cancer journeys and define surveillance schedules. However, there is
currently no formal cancer-related care or support offered to long-
term survivors beyond routine hospital follow-up.
The objectives of this study were to investigate health status,
psychologicalmorbidity, and supportive care needs in long-termcan-
cer survivors in the United Kingdom and to identify the factors that
predict poor health status, anxiety and depression caseness, and un-
met needs in this population.
METHODS
Study Design and Sample
A cross-sectional postal survey was conducted across the populations
served by the Northern and Yorkshire Cancer Registry and Information Ser-
vice and the Oxford Cancer Intelligence Unit in the United Kingdom. Poten-
tial participants were identified through these two regional cancer registries,
which thendistributed the questionnaires to the PCPswhowere caring for the
identified survivors. The PCPs were asked to forward questionnaires to the
selected participants, provided they met the inclusion criteria and if it was
deemed appropriate.
Astratifiedrandomsampleof2,400long-termsurvivorsofbreast(n800),
colorectal (n  800), and prostate (n  800) cancers diagnosed between
January 1, 1993, and December 31, 2003, was selected. Our definition of a
long-term survivor was a person who had survived at least 5 years from
diagnosis. Survivors were also stratified by sex (colorectal cancer) and years
since diagnosis (5 to 7, 9 to 11, or 14 to 16 years). Survivors 5 to 7 years from
diagnosiswereoversampled(ratio2:1:1) tominimize theeffectof recall biason
questions relating todischarge fromfollow-up(datanotpresented).Exclusion
criteria were male breast cancer survivors; diagnosis of recurrence, metastatic
disease, or secondprimary cancer; age younger than30or older than100 years
at diagnosis; and registrationwith a different PCPor living outside the recruit-
ment area.
Measures
The questionnaire employed the European Quality of Life–5 Dimen-
sions (EQ-5D),24 Hospital Anxiety and Depression Scale (HADS),25 Cancer
Survivors’UnmetNeeds(CaSUN)Measure,26 andTraitScaleof theStateTrait
Anxiety Inventory (STAI).27
Each of the five dimensions in the EQ-5D (mobility, self-care, activities,
pain/discomfort, anxiety/depression) is scored from 1 (no problem) to 3
(extreme problem), generating a profile (eg, 11232) that can be used to calcu-
late a single index score (range,0.594 to 1.000).28 The EQ-5D also generates
a self-rating of health-related quality of life scored from 0 to 100 on a visual
analog scale (VAS). EQ-5D profile, index, and VAS scores were used in the
current study.
TheHADSgenerates separate subscale scores for anxiety anddepression.
Subscale scores of 8 to 10 indicate possible cases of anxiety or depression, and
subscale scoresof 11orhigher indicateprobable casesof anxietyordepression.
TheCaSUN is ameasure of cancer-related needs experiencedwithin the
preceding month. It includes 35 need items, which respondents are asked to
indicate as not applicable, met, or unmet. Unmet needs are rated as weak,
moderate, or strong. The need items factorize onto five domains: comprehen-
sive cancer care, existential survivorship, information, quality of life, and
relationships.The current study included28of theCaSUNitems; the excluded
items all factorized onto the existential survivorship domain (excluded items
listed in Appendix Table A1, online only).
Statistical Analysis
Data analysis was undertaken using SPSS software version 16.0 (SPSS,
Chicago, IL). Kolmogorov-Smirnov tests were used to test for normality. We
used a complete case analysis strategy; therefore, respondents with missing
values on a variablewere excluded fromanalyses of that variable. Respondents
withmissing values for anyquestionona standardizedmeasurewere excluded
from all analyses of that measure. Data were analyzed by type of cancer and
years since diagnosis. Percentages and 95% CIs were used to compare the
sample with population norms and to compare groups within the sample.
Logistic regression was used to identify factors that predict poor health
status, anxiety and depression caseness, and unmet needs. Predictor variables
were selected based on existing literature8,17,29-32 and potential clinical utility
of identifyingmodifiable risk factors. The variables entered into the regression
model were geographic region, age, sex, type of cancer, years since diagnosis,
trait anxiety score, treatment (surgery, radiotherapy, chemotherapy, hor-
monal therapy), discharge status (self-reported), and satisfaction with dis-
charge. A significantly lower than expected number of respondents reported
comorbidities meeting Charlson index criteria33,34; hence, the comorbidities
variable was excluded from the regression analysis.
The logistic regression outcomes were: first, score of 1 on all dimensions
of the EQ-5D versus score of 2 or higher on at least one dimension of the
EQ-5D; second, HADS anxiety score lower than 8 versusHADS anxiety score
of 8 or higher; third, HADS depression score lower than 8 versus HADS
depression score of 8 or higher; and fourth, nounmet needs versus at least one
unmet need on the CaSUN. Because of the large number of variables entered
into the regressionanalyses, onlyvariables contributing to themodel atP .01
were accepted as statistically significant; these are discussed in Results.
RESULTS
Recruitment and Sample Characteristics
The recruitment process is shown in Figure 1. The cancer regis-
tries supplied basic demographic information for all nonrespondents.
T-tests indicated that respondents and nonrespondents did not differ
significantly in termsofage, sex, typeofcancer,oryears sincediagnosis
(two-tailed P  .05). Therefore, on these variables, the sample of
respondents was representative of all those survivors identified as
eligible by the registries and sent the questionnaire by the PCPs.
Themean age for the sample was 71.6 years (standard deviation,
9.9 years; range, 42 to 92 years), and 45.8%of respondents weremale.
There were more responses from breast cancer survivors, with com-
parable numbers from colorectal and prostate cancer survivors. The
largest proportion of the respondents was 5 to 7 years fromdiagnosis,
with comparable numbers 9 to 11 years and 14 to 16 years from
diagnosis, approximating the distribution of the initial sample identi-
fied. The mean trait anxiety score on the STAI for the overall sample
was 34.0 (standard deviation, 10.0), which is consistent with popula-
tion norms.27 Additional demographic data for the overall sample are
listed in Table 1. Data on age, sex, type of cancer, and years since
diagnosis were provided by the cancer registries; all other demo-
graphic and clinical data were self-reported.
Health Status
The mean EQ-5D index and VAS scores for the overall sample
and those for each cancer type and length of time since diagnosis were
consistent with or better than population norms (Table 2).35 Both
mean and median scores are reported because of the significantly
skewed distribution of the data (P .001).
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Psychological Morbidity
The possible (HADS score 8-10) and probable (HADS score
 11) cases of anxiety and depression in the overall sample and in
survivors with different types of cancer and with different lengths of
time since diagnosis were consistent with or below population norms
(Table 3).25,36
Unmet Needs
In total, 538 respondents (81.6%) completed the CaSUN. The
results showed 47.4% of these respondents reported at least one un-
met need (any strength). This percentage decreased to 36.6% when
including only respondents who reported at least one moderate or
strong unmet need. There were no significant differences between the
proportions of respondents reporting at least one unmet need or at
least one moderate or strong unmet need across cancer types or time
since diagnosis.
Themost frequently endorsedunmetneeds and themeanratings
(strength) of these needs are listed inTable 4. The existential survivor-
ship need for “help to managemy concerns about the cancer coming
back” was the most frequently reported unmet need. After this, the
highest frequency and strength of reported unmet needs were related
to comprehensive cancer care (eg, “I need to know that allmy doctors
talk to each other to coordinate my care”). Other needs concerning
existential survivorship (eg, “I need help to reduce stress in my life”)
*
Responses by
survivors (registered 
to nonresponding
PCPs; n = 63)
Responses by
survivors
(supposedly
excluded by
PCPs; n = 9)
Random sample
of survivors
(n = 2,400)
Inclusions by
registries
(n = 1,860; 77.5%)
Responses by
PCPs
(n = 1,456; 78.3%)
Inclusions by
PCPs (n = 1,133; 
77.8% of PCP
responses, 60.9%
of registry
inclusions)
Responses by
survivors
(registered to
responding
PCPs; n = 587)
All respondents
(n = 659; survivor 
response rate, 
51.7%*)
Exclusions by registries
(deaths, out of recruitment
area, second cancers,
missing data; n = 540)
PCPs did not respond
(n = 404)
Exclusions by PCPs (deaths,
metastases, recurrences,
not registered, other
criterion for unsuitability;
n = 323)
Survivors did not respond
(n = 415)
Survivors (registered to
responding PCPs) returned
nonparticipation form
(n = 131)
Survivors (registered to
nonresponding PCPs)
returned nonparticipation
form
(n = 16)
Nonresponding survivors
(registered to nonresponding
PCPs) from which another 
survivor responded
(n = 54)
Respondents     + Respondents     + Respondents
included by from nonresponding  excluded by
PCPs  PCPs PCPs
(n = 587) (n = 63) (n = 9)   659
Inclusions by    +  Respondents    +  Respondents    +  Respondents   +  Nonrespondents  1,275
PCPs from  excluded by (nonparticipation from nonresponding
(n = 1,133) nonresponding PCP PCPs form) from non- PCP from whom another
 (n = 63) (n = 9) responding PCPs survivor responded
   (n = 16) (n = 54)
= = 51.7%
Fig 1. CONSORT diagram. Because of
our reliance on primary care physicians
(PCPs) to inform us of survivors’ inclusion/
exclusion in the study, we were unable to
obtain a definitive number of survivors to
whom the questionnaire was sent. We
have presented our response rates con-
servatively and the recruitment process
transparently to highlight the high nonre-
sponse rate at PCP and survivor level in
this study.
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and information (eg, “I need information provided in away that I can
understand”) also ranked among the top 10 unmet needs.
A breakdown of unmet needs by type of cancer and years since
diagnosis showed that the following three items were within the top
five most frequently endorsed unmet needs for all groups, although
theorder varied: coordinatedhealth care, health care services available
locally, and involvement in themanagement of their health care. The
needs for complaints to be addressed, more accessible hospital park-
ing, and the best medical care also featured frequently in the top five
unmetneeds. Theneed for help tomanage concerns about recurrence
ranked in the top six unmet needs for all groups; it was the most
frequently endorsed unmet need for breast cancer survivors (24.5%)
and those survivors 5 to 7 years from diagnosis (22.1%). Survivors
were asked if they had other needs, but there were no consistent
references to additional needs not included in the CaSUN.
Survivors with possible or probable anxiety on the HADS re-
ported significantly higher numbers of unmet needs on the CaSUN
(possible: mean, 4.9; 95% CI, 3.41 to 6.39; probable: mean, 6.9; 95%
CI, 4.63 to 9.18) comparedwith survivors with no anxiety (mean, 2.1;
95% CI, 1.73 to 2.47). Survivors with possible depression on the
HADS reported significantly higher numbers of unmet needs on the
CaSUN (mean, 5.9; 95%CI, 3.27 to 8.53) comparedwith survivors with
nodepression (mean,2.5; 95%CI, 2.11 to2.89). Survivorswithprobable
depression also reported higher numbers of unmet needs (mean, 6.0;
95% CI, 1.10 to 10.90) compared with survivors with no depression,
but the difference did not reach statistical significance, possibly be-
cause of the small number of survivors with probable depression.
Predictors of Health Status, Psychological Morbidity,
and Unmet Needs
Logistic regression models (Table 5) showed that trait anxiety
significantly predicted problems in at least one EQ-5D dimension
Table 1. Patient Demographics and Disease Characteristics for
Overall Sample
Characteristic
Patients (N  659)
No. %
Age, years
Mean 71.6
SD 9.9
Trait anxiety
Mean 34.0
SD 10.0
Region
NYCRIS population 266 40.4
OCIU population 393 59.6
Sex
Male 302 45.8
Female 357 54.2
Relationship status
Single 27 4.2
Married 459 71.1
Widowed 117 18.1
Divorced/separated 43 6.7
Total 646
Living status
Alone 165 25.4
With spouse/partner 458 70.6
With other family 21 3.2
With other people 5 0.8
Total 649
Employment status
Paid work 106 16.5
Unemployed 8 1.2
Retired 492 76.3
Long-term disability/illness 18 2.8
Other 21 3.3
Total 645
Ethnicity
White 631 97.5
Black Caribbean 6 0.9
Black other 2 0.3
Indian 3 0.5
Pakistani 1 0.2
Chinese 1 0.2
Other 3 0.5
Total 647
Educational status
O-level 107 16.6
A-level 60 9.3
Clerical/commercial qualification 89 13.8
College/university degree 152 23.6
None of these 237 36.7
Total 645
Type of cancer
Breast 258 39.2
Colorectal 205 31.1
Prostate 196 29.7
Years since diagnosis
5-7 388 58.9
9-11 142 21.5
14-16 129 19.6
(continued on following column)
Table 1. Patient Demographics and Disease Characteristics for Overall
Sample (continued)
Characteristic
Patients (N  659)
No. %
Treatment†
Surgery 505 77.0
Radiotherapy 315 48.0
Chemotherapy 137 20.9
Hormonal therapy 230 35.1
Other treatments 22 3.3
Comorbidities
At least one 87 13.2
None 572 86.8
Discharge status (self-reported)
Discharged 429 66.2
Not discharged 219 33.8
Total 648
Satisfaction with discharge
Satisfied 365 90.6
Not satisfied 38 9.4
Total 403
Abbreviations: NYCRIS, Northern and Yorkshire Cancer Registry Information
Services; OCIU, Oxford Cancer Intelligence Unit; SD, standard deviation.
Total excludes those with missing data.
†Many survivors had received more than one treatment modality.
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of health (P .001),HADS anxiety scores of 8 or higher (P .001),
HADS depression scores of 8 or higher (P .001), and at least one
unmet need on the CaSUN (P .001). Age significantly predicted
problems in at least one dimension of health (P  .01), but the
relationship between age and health status was unclear. Receipt of
hormonal therapy (P .01), nondischarged status (P .01), and
dissatisfaction with discharge (P  .01) significantly predicted at
least one unmet need on the CaSUN. No other variables were
predictive of health status, anxiety or depression caseness, or un-
met needs at the higher level of statistical significance (P .01).
DISCUSSION
The current study found that a majority of long-term cancer survivors
report good health and do not have psychological morbidity or large
numbersofunmetsupportivecareneeds.Inlinewithrecentinternational
research, health status and overall cases of anxiety and depression were
consistent with or better than population norms.37-39 Hence, long-term
breast, colorectal, and prostate cancer survivors who have no signs of
recurrence seem tohave adjustedwell 5 to 16 years after diagnosis.
Fewer than half of the respondents to the CaSUN in the current
study reported one or more unmet need; approximately one third re-
ported at least onemoderate or strong unmet need. The needs that were
reported primarily concerned comprehensive cancer care, such as the
need toknow that health care is coordinated andavailable locally and the
need for more accessible hospital parking. The focus on these largely
practical needs is perhaps surprising in a health economy with universal
access. Interestingly, many of themore psychosocial needs (ie, impact of
cancer on relationships, body image, quality of life, social life, and so on)
were not frequently endorsed by the long-term survivors in this study.
Despite theoverall encouragingfindings, aminorityof long-term
survivors in the current study reported poor health status, increased
psychological morbidity, and/or moderate or strong unmet supportive
care needs. More than one fifth of respondents to the CaSUN indicated
the need for help inmanaging concerns regarding recurrence. Such sur-
vivors may benefit from long-term support, and a number of interven-
tions are being developed to specifically address this issue.40-42
The National Cancer Survivorship Initiative has recently priori-
tized the need for research to enhance understanding of survivorship
and improve aftercare for cancer survivors in the United Kingdom.21
This is the first United Kingdom study to report the health and sup-
portive careneedsof long-termcancer survivors.Becauseof the lackof
existing literature, the current findings are important in providing
insight into this ever-growing population. The overall sample was
large and representative of two regions in theUnitedKingdom.There
was representation of three common types of cancer and of survivors
at different stages of long-term survivorship.
A limitationof the studywas theuseof themodifiedCaSUN.The
CaSUNwas developed in a different health care setting on survivors 1
to 15 years from diagnosis (mean, 2.3 years), and some of the needs it
assesses might be more relevant earlier in the survivor trajectory.26
Furthermore, the items excluded from the CaSUN in the current
study might have been identified as important unmet needs by our
sample. Although no respondents made reference to any of the ex-
cluded needs when asked to identify other needs, the current findings
are perhaps an underestimation of the number of unmet existential
survivorship needs experienced by long-term cancer survivors.
Additional limitations are the potential self-selecting and PCP-
selecting samplebiases. Ethical approval for this studywas consequent
on the approach to the survivors beingmade by their PCPs. The PCPs
were given explicit exclusion criteria, but despite this, they may have
also excluded survivors with comorbidities. This potential bias may
have contributed to low levels of comorbidities, low anxiety and de-
pression caseness, and good overall health status in our sample.
Table 2. EQ-5D Health Status: Comparison of Sample With Population Norms
EQ-5D No. Median Mean 95% CI of Mean
Index (age and sex standardized population norm  0.77)
All 636 0.81 0.80 0.78 to 0.81†
Type of cancer
Breast 250 0.80 0.77 0.74 to 0.80
Colorectal 196 0.85 0.80 0.77 to 0.84
Prostate 190 0.85 0.82 0.79 to 0.85†
Years since diagnosis
5-7 375 0.81 0.79 0.77 to 0.82
9-11 136 0.80 0.79 0.75 to 0.83
14-16 125 0.85 0.81 0.77 to 0.85
VAS (age and sex standardized population norm  76.5)
All 611 79.0 75.5 74.3 to 76.7
Type of cancer
Breast 240 79.0 75.6 73.6 to 77.5
Colorectal 186 79.0 75.3 73.1 to 77.5
Prostate 185 79.0 75.5 73.4 to 77.6
Years since diagnosis
5-7 357 79.0 75.4 73.8 to 77.0
9-11 134 80.0 75.3 72.7 to 77.9
14-16 120 79.0 75.9 73.3 to 78.5
Abbreviations: EQ-5D, European Quality of Life–5 Dimensions; VAS, visual analog scale.
Age and sex standardized population norms calculated by weighting population norms for different age groups/sexes according to sample distribution.
†Population norm outside 95% CI of sample mean.
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The existing literature on the psychosocial implications of long-
term cancer survivorship is sparse, and there are few studies to com-
pare with this study. The current findings do support a recent
systematic review that concluded that most survivors experience few
problems 5 or more years after diagnosis, yet a minority consistently
describe quality-of-life issues and physical/psychological problems
associated with cancer and its treatment.15 Consistent with our find-
ings, the authors of the CaSUN found that the most frequently en-
dorsed unmet need in samples of breast and gynecologic cancer
survivors was for help with concerns about recurrence.43,44 Other
studies have also identified fear of recurrence as the most significant
concern for long-term cancer survivors.8,45,46
Numerous predictors of poor psychosocial outcomes in long-term
cancersurvivorshavebeenproposed.8,17,29-32OneUSstudyfounddispo-
sitionaloptimism/pessimismtobethemostconsistentpredictorofcancer
worries, anxiety, anddepression.8This is in linewith thefinding fromthe
current study that trait anxiety predicts those survivors at risk of poor
health status, anxiety anddepression, andunmet needs. The finding that
dissatisfaction with discharge is predictive of unmet needs is novel and,
although based on small numbers, warrants additional research. Other
research priorities include prospective studies to risk-stratify patients ac-
cording to need, investigations of the supportive care needs in other
cancer populations, and additional research on intervention studies to
better target the needs of long-termcancer survivors.
Table 3. HADS Anxiety and Depression: Comparison of Sample With Population Norms
HADS No.
Possible Case Probable Case
% 95% CI % 95% CI
Anxiety (population norm  20.6, possible case; 12.6, probable case)
All 627 13.6 10.9 to 16.3 9.3 7.0 to 11.6
Type of cancer
Breast 248 18.1 13.3 to 23.0 12.9 8.7 to 17.1
Colorectal 190 8.9 4.8 to 13.0 10.0 5.7 to 14.3
Prostate 189 12.2 7.5 to 16.9 3.7 1.0 to 6.4
Years since diagnosis
5-7 367 13.1 9.6 to 16.6 8.2 5.4 to 11.0
9-11 134 15.7 9.5 to 21.9 11.9 6.3 to 17.5
14-16 126 12.7 6.8 to 18.6 9.5 4.3 to 14.7
Depression (population norm  7.8, possible case; 3.6, probable case)
All 633 7.3 5.3 to 9.3 2.1 1.0 to 3.2
Type of cancer
Breast 254 6.3 3.3 to 9.3 2.8 0.8 to 4.8
Colorectal 191 6.8 3.2 to 10.4 0.5 0.0 to 1.5
Prostate 188 9.0 4.9 to 13.1 2.7 0.4 to 5.0
Years since diagnosis
5-7 372 7.8 5.1 to 10.5 2.4 0.8 to 4.0
9-11 135 5.9 1.9 to 9.9 1.5 0.0 to 3.6
14-16 126 7.1 2.6 to 11.7 1.6 0.0 to 3.8
Abbreviation: HADS, Hospital Anxiety and Depression Scale.
Population norm outside 95% CI of sample mean.
Table 4. Survivors’ Most Frequently Endorsed Unmet Needs
Rank CaSUN Need Domain
Percent of
Patients
(n  538)
Mean
Rating
1 I need help to manage my concerns about the cancer coming back Existential survivorship 20.8 2.6
2 I need to know that all my doctors talk to each other to coordinate my care Comprehensive cancer care 20.6 3.2
3 I need local health care services that are available when I require them Comprehensive cancer care 18.8 3.3
4 I need more accessible hospital parking Comprehensive cancer care 18.4 3.4
5 I need to feel like I am managing my health together with the medical team Comprehensive cancer care 18.0 3.1
6 I need any complaints regarding my care to be properly addressed Comprehensive cancer care 14.7 3.4
7 I need the very best medical care Comprehensive cancer care 14.5 3.5
8 I need help to reduce stress in my life Existential survivorship 13.2 2.3
9 I need information provided in a way that I can understand Information 12.8 3.0
10 I need an ongoing case manager from whom I can find out about services
whenever they are needed
No domain 12.6 2.7
Abbreviation: CaSUN, Cancer Survivors’ Unmet Needs.
Unmet needs rated as weak (2), moderate (3), or strong (4).
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The key challenges for health care professionals providing long-
term survivorship care are, first, to identify the survivors requiring
additional help at the point of discharge or later in survivorship and,
second, to establish the most effective interventions for those long-term
survivors with ongoing needs. Awareness of the potential risk factors (ie,
high trait anxiety, receipt of hormonal therapy, nondischarged status,
dissatisfactionwithdischarge)mighthelp toward identifying those survi-
vors requiring further follow-up, although the lack of consistency in the
risk factors identified in the literature highlights the importance of rou-
tinely screening all survivors at the point of discharge.47
The introduction of SCPswill enable PCPs to provide better care
to long-term cancer survivors. SCPs are tailored documents that in-
form PCPs about survivors’ diagnosis, treatment, and ongoing man-
agement requirements.48 SCPs are currently being trialed in the
United Kingdom and, if successful, are likely to be implemented.49
The introduction of postdischarge reviews between PCPs and cancer
survivors could also help in the identification of those long-term
survivors requiring additional support.
The findings of the current study suggest that a majority of
long-termcancer survivors have goodhealth andarenot experiencing
psychological morbidity or large numbers of unmet supportive care
needs. A minority of long-term survivors may benefit from ongoing
support, and the current study identified potential predictors of un-
met supportive care needs. The identification and support of those
long-term cancer survivors with unmet needs is a key challenge for
health care professionals caring for this population.
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Table 5. Logistic Regression Analysis to Identify Variables Associated With Poor Health Status, Anxiety and Depression Caseness, and Unmet Needs
Characteristic
Health Problems
on EQ-5D
HADS Anxiety
Caseness
HADS Depression
Caseness
At Least One Unmet
Need on CaSUN
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
No. of survivors included in logistic regression 514 506 509 458
Region
OCIU population
NYCRIS population 0.85 0.56 to 1.30 0.58 0.31 to 1.11 1.83 0.86 to 3.89 0.79 0.52 to 1.20
Age, years 1.06† 1.03 to 1.08 1.00 0.97 to 1.04 1.06‡ 1.01 to 1.11 0.97‡ 0.95 to 1.00
Sex
Female
Male 0.90 0.43 to 1.89 0.51 0.14 to 1.83 0.87 0.20 to 3.80 1.60 0.75 to 3.39
Type of cancer
Colorectal
Breast 1.58 0.70 to 3.55 1.99 0.64 to 6.15 0.46 0.11 to 1.93 0.48 0.21 to 1.09
Prostate 0.93 0.45 to 1.92 1.93 0.50 to 7.47 2.91 0.63 to 13.34 0.61 0.29 to 1.29
Years since diagnosis
5-7
9-11 0.97 0.58 to 1.63 2.34‡ 1.11 to 4.93 0.41 0.15 to 1.10 1.19 0.72 to 1.98
14-16 0.63 0.37 to 1.09 0.97 0.43 to 2.19 0.75 0.28 to 1.98 0.93 0.53 to 1.60
Trait anxiety 1.11† 1.08 to 1.14 1.27† 1.21 to 1.33 1.20† 1.14 to 1.26 1.06† 1.04 to 1.09
Radiotherapy
No
Yes 0.91 0.56 to 1.47 0.56 0.26 to 1.20 2.90‡ 1.06 to 7.94 1.28 0.79 to 2.09
Chemotherapy
No
Yes 0.98 0.57 to 1.68 1.61 0.70 to 3.66 1.04 0.36 to 3.06 0.93 0.54 to 1.59
Surgery
No
Yes 1.12 0.62 to 2.03 0.83 0.33 to 2.09 2.15 0.61 to 7.51 1.22 0.66 to 2.26
Hormonal therapy
No
Yes 1.13 0.67 to 1.91 0.63 0.30 to 1.33 1.37 0.53 to 3.52 2.09† 1.24 to 3.52
Discharge status
Satisfied
Dissatisfied 0.99 0.63 to 1.56 1.05 0.29 to 3.80 1.78 0.43 to 7.38 4.39† 1.79 to 10.74
Not discharged 1.47 0.58 to 3.73 1.90 0.96 to 3.78 0.54 0.23 to 1.27 2.03† 1.28 to 3.21
NOTE. All variables are mutually adjusted.
Abbreviations: CaSUN, Cancer Survivors’ Unmet Needs; EQ-5D, European Quality of Life–5 Dimensions; HADS, Hospital Anxiety and Depression Scale; NYCRIS,
Northern and Yorkshire Cancer Registry Information Services; OCIU, Oxford Cancer Intelligence Unit; OR, odds ratio.
Reference category.
†Significant at P  .01.
‡Significant at P  .05.
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